Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Santos, Breno R."" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
Autorzy:
Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Centre of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Hughes MD; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Salata R; Case Western Reserve University, Cleveland, Ohio, USA.
Godfrey C; Division of AIDS, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
McCarthy C; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Mugyenyi P; Joint Clinical Research Center, Kampala, Uganda.
Hogg E; Social & Scientific Systems, Inc., a DLH Holdings Company, Silver Spring, Maryland, USA.
Gross R; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Bukuru A; Joint Clinical Research Center, Kampala, Uganda.
Makanga M; Kenya Medical Research Institute/Center of Disease Control, Kisumu, Kenya.
Badal-Aesen S; Clinical HIV Research Unit, Helen Joseph Hospital, University of Witwatersrand, Johannesburg, South Africa.
Mave V; BJ Medical College Clinical Research Site, Pune, India.
Ndege BW; Moi University Clinical Research Center (MUCRC) CRS, Eldoret, Kenya.
Fontain SN; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti.
Samaneka W; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
Secours R; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti.
Van Schalkwyk M; Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa.
Mngqibisa R; Durban International Clinical Research Site, King Edward Hospital, Enhancing Care Foundation, Durban, South Africa.
Mohapi L; Soweto AIDS Clinical Trials Group, Clinical Research Site, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Valencia J; Barranco Clinical Research Site, Lima, Peru.
Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Montalban E; San Miguel Clinical Research Site, Lima, Peru.
Munyanga C; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
Chagomerana M; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
Santos BR; Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Brazil.
Kumarasamy N; CART, Clinical Research Site, VHS Infection Disease Medical Centre, Chennai, India.
Kanyama C; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
Schooley RT; Division of Infectious Diseases, University of California, San Diego, California, USA.
Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Wallis CL; BARC-South Africa and Lancet Laboratories, Johannesburg, South Africa.
Collier AC; University of Washington School of Medicine, University of Washington, Seattle, Washington, USA.
Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Pokaż więcej
Corporate Authors:
A5288 Study team
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jun; Vol. 25 (6), pp. e25905.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Protease Inhibitors*/therapeutic use
HIV-1*/genetics
Anti-Retroviral Agents/therapeutic use ; Darunavir/therapeutic use ; Female ; Humans ; Male ; Nitriles ; Pyrimidines ; RNA/therapeutic use ; Raltegravir Potassium/adverse effects ; Ritonavir/therapeutic use ; Viral Load
Czasopismo naukowe
Tytuł:
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study.
Autorzy:
Shivakoti R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Present Address: Department of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St, Room 705, New York, NY, 10032, USA. .
Gupte N; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Tripathy S; National AIDS Research Institute, Pune, India.; Present Address: National Institute of Research in Tuberculosis, Chennai, India.
Poongulali S; YR Gaitonde Center for AIDS Research and Education, Chennai, India.
Kanyama C; UNC Lilongwe, Lilongwe, Malawi.
Berendes S; Malawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi.; Present Address: Liverpool School of Tropical Medicine, Liverpool, UK.
Cardoso SW; STD/AIDS Clinical Research Laboratory, Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Santos BR; Hospital Nossa Senhora de Conceiçã, Porto Alegre, Brazil.
La Rosa A; Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
Mwelase N; Department of Medicine, University of Witwatersrand, Johannesburg, South Africa.
Pillay S; Durban International Clinical Research Site, Durban University of Technology, Durban, South Africa.
Samaneka W; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
Riviere C; Les Centres GHESKIO, Port-Au-Prince, Haiti.
Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai, Thailand.
Bollinger RC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Balagopal A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Semba RD; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christian P; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Present Address: Bill and Melinda Gates Foundation, Seattle, USA.
Campbell TB; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA.
Gupta A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Corporate Authors:
NWCS 319 and PEARLS Study Team
Źródło:
BMC medicine [BMC Med] 2018 Sep 24; Vol. 16 (1), pp. 161. Date of Electronic Publication: 2018 Sep 24.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/blood
HIV Infections*/complications
HIV Infections*/drug therapy
Biomarkers/*blood
Inflammation/*blood
Micronutrients/*blood
Tuberculosis/*complications
Adult ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/methods ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Trace Elements/blood ; Treatment Failure ; Tuberculosis/drug therapy ; Young Adult
Czasopismo naukowe
Tytuł:
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
Autorzy:
Schlusser KE; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Pilcher C; Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, United States of America.
Kallas EG; University of São Paulo, São Paulo, Brazil.
Santos BR; Grupo Hospitalar Conceicao, Porto Alegre, Brazil.
Deeks SG; Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, United States of America.
Facente S; Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, United States of America.
Keating SM; Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, United States of America.; Blood Systems Research Institute, San Francisco, California, United States of America.
Busch MP; Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, United States of America.; Blood Systems Research Institute, San Francisco, California, United States of America.
Murphy G; Public Health England, London, United Kingdom.
Welte A; The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Quinn T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Baltimore, MD, United States of America.
Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Laeyendecker O; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Baltimore, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Feb 23; Vol. 12 (2), pp. e0172283. Date of Electronic Publication: 2017 Feb 23 (Print Publication: 2017).
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Dried Blood Spot Testing*
HIV Infections/*blood
HIV-1/*isolation & purification
Cross-Sectional Studies ; HIV Infections/epidemiology ; Humans ; Incidence ; Viral Load
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies